Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Alfred

Showing results (331-340 of 434) with videos related to

Pageof 44
Sort By:
World Journal of Urology|August 20, 2016
MRI-guided focal laser ablation for prostate cancer followed by radical prostatectomy: correlation of treatment effects with imagingJoyce G R Bomers, Erik B Cornel, Jurgen J Fütterer, et al.
Investigative Radiology|January 13, 2010
Feasibility of 3T dynamic contrast-enhanced magnetic resonance-guided biopsy in localizing local recurrence of prostate cancer after external beam radiation therapyDerya Yakar, Thomas Hambrock, Henkjan Huisman, et al.
European Urology Focus|February 26, 2018
Adjuvant recMAGE-A3 Immunotherapy After Cystectomy for Muscle-invasive Bladder Cancer: Lessons Learned from the Phase 2 MAGNOLIA Clinical TrialPeter F A Mulders, Luis Martínez-Piñeiro, Axel Heidenreich, et al.
BJU International|February 25, 2021
External validation of the Memorial Sloan Kettering Cancer Centre and Briganti nomograms for the prediction of lymph node involvement of prostate cancer using clinical stage assessed by magnetic resonance imagingTimo F W Soeterik, Tom A Hueting, Bas Israel, et al.
European Urology Oncology|June 19, 2022
Intermediate-risk Non-muscle-invasive Bladder Cancer: Updated Consensus Definition and Management Recommendations from the International Bladder Cancer GroupWei Shen Tan, Gary Steinberg, J Alfred Witjes, et al.
Cancers|August 12, 2023
Vaccination against Extracellular Vimentin for Treatment of Urothelial Cancer of the Bladder in Client-Owned DogsDiederik J M Engbersen, Judy R van Beijnum, Arno Roos, et al.
World Journal of Urology|December 11, 2014
Urinary cytokines in patients treated with intravesical mitomycin-C with and without hyperthermiaTom J H Arends, Johannes Falke, Rianne J M Lammers, et al.
BJU International|August 4, 2020
Comparison of the performances of the ADXBLADDER test and urinary cytology in the follow-up of non-muscle-invasive bladder cancer: a blinded prospective multicentric studyPaulo Gontero, Emanuele Montanari, Morgan Roupret, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
No Association Between BCG Instillations and COVID-19 Incidence in a Dutch Non-Muscle Invasive Bladder Cancer CohortMoniek van Zutphen, Lambertus A L M Kiemeney, Ursula T H Oldenhof, et al.
The Journal of Urology|April 22, 2020
Diagnostic Accuracy of MCM5 for the Detection of Recurrence in Nonmuscle Invasive Bladder Cancer Followup: A Blinded, Prospective Cohort, Multicenter European StudyMorgan Roupret, Paolo Gontero, Stuart R C McCracken, et al.
Pageof 44

Showing results (331-340 of 434) with videos related to

Sort By:
Pageof 44
World Journal of Urology|August 20, 2016
MRI-guided focal laser ablation for prostate cancer followed by radical prostatectomy: correlation of treatment effects with imagingJoyce G R Bomers, Erik B Cornel, Jurgen J Fütterer, et al.
Investigative Radiology|January 13, 2010
Feasibility of 3T dynamic contrast-enhanced magnetic resonance-guided biopsy in localizing local recurrence of prostate cancer after external beam radiation therapyDerya Yakar, Thomas Hambrock, Henkjan Huisman, et al.
European Urology Focus|February 26, 2018
Adjuvant recMAGE-A3 Immunotherapy After Cystectomy for Muscle-invasive Bladder Cancer: Lessons Learned from the Phase 2 MAGNOLIA Clinical TrialPeter F A Mulders, Luis Martínez-Piñeiro, Axel Heidenreich, et al.
BJU International|February 25, 2021
External validation of the Memorial Sloan Kettering Cancer Centre and Briganti nomograms for the prediction of lymph node involvement of prostate cancer using clinical stage assessed by magnetic resonance imagingTimo F W Soeterik, Tom A Hueting, Bas Israel, et al.
European Urology Oncology|June 19, 2022
Intermediate-risk Non-muscle-invasive Bladder Cancer: Updated Consensus Definition and Management Recommendations from the International Bladder Cancer GroupWei Shen Tan, Gary Steinberg, J Alfred Witjes, et al.
Cancers|August 12, 2023
Vaccination against Extracellular Vimentin for Treatment of Urothelial Cancer of the Bladder in Client-Owned DogsDiederik J M Engbersen, Judy R van Beijnum, Arno Roos, et al.
World Journal of Urology|December 11, 2014
Urinary cytokines in patients treated with intravesical mitomycin-C with and without hyperthermiaTom J H Arends, Johannes Falke, Rianne J M Lammers, et al.
BJU International|August 4, 2020
Comparison of the performances of the ADXBLADDER test and urinary cytology in the follow-up of non-muscle-invasive bladder cancer: a blinded prospective multicentric studyPaulo Gontero, Emanuele Montanari, Morgan Roupret, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
No Association Between BCG Instillations and COVID-19 Incidence in a Dutch Non-Muscle Invasive Bladder Cancer CohortMoniek van Zutphen, Lambertus A L M Kiemeney, Ursula T H Oldenhof, et al.
The Journal of Urology|April 22, 2020
Diagnostic Accuracy of MCM5 for the Detection of Recurrence in Nonmuscle Invasive Bladder Cancer Followup: A Blinded, Prospective Cohort, Multicenter European StudyMorgan Roupret, Paolo Gontero, Stuart R C McCracken, et al.
Pageof 44